Table 1 Countries with high endemic rates (>10 cases/100,000 population) and/or > =1 epidemic over the last 20 years

African Region

Angola

1994–2000

19–230

*

[8]

Benin

1980–1999

6–57

[9, 10]

Burkina Faso

2004–2009

26–187

[11, 12]

Burundi

1980–1999

158

[9]

Cameroon

1–224

[13]

Centrafique

2004–2009

3 3–19.4

[12]

Chad

9.6–15.9

[12]

Cote de Ivoire

1980–1999

0-6

[14]

Despite its relatively low attack rate, Cote de Ivoire is included in this table due to its location in the meningitis belt

Ethiopia

0–104

A

[9, 10]

Gambia

4–165

[9, 15]

Ghana

0–108

[9, 15]

Guinea

0–17

[12]

Guinea Bissau

0–133

[9]

Kenya

1990

267

[16]

Mali

2004–2009

2.6–12.9

[12]

Mauritania

1980–1999

0–14

[9]

Namibia

4–165

[9]

Niger

2004–2009

7.8–90.7

[17]

Nigeria

0.7–52.6

[12]

RD Congo

7.3–23.7

[12]

Rwanda

1980–1999

0–28

[9]

Senegal

0–53

Incidence >50 in 1983

Tanzania

1980–1999

0–19

Togo

2004–2009

6–13.2

[12]

Uganda

1980–1999

0–18

[14]

Eastern Mediterranean Region

Sudan

2008

*

A

[12]

Despite lack of data Sudan is included in this table due to its location in the meningitis belt

Saudi Arabia

2000

A, W-135

[18]

225 cases in month after 2000 Hajj season. Data from Saudi Arabia mostly includes cases from the Hajj season.

European Region

No country in this region is in the high rate category

Region of the Americas

Uruguay

2001

30 (pre-vaccine)

B

[19]

Vaccine comprising serogroup C capsular polysaccharide and the outer membrane vesicles of serogroup B meningococcus was used

1.6 (post-vaccine)

South-East Asia Region

No country in this region is in the high rate category

Western Pacific Region

New Zealand

1991–2000

17.4 (pre-vaccine)

B

[20]

An OMV vaccine for Serogroup B was introduced in 2004

2.6 (post-vaccine)

Mongolia

1994–1995

80-90

A

[21]